L3VLUP
ProSign in

TXG · LLY in the 13F filings

Two to four stocks side by side among the 95 tracked managers: who lists them, how that has moved, who bought and sold in a quarter, and which managers hold more than one.

TXGLLY
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023

Holders over time

Tracked managers listing each stock every quarter, at least, or their combined reported value. A gap is a quarter in which no tracked manager listed it. Click a quarter to compare there.
  • TXG
  • LLY
0204060202120222023202420252026
Holders and value by quarter
QuarterTXGLLY
Q3 202017 holders, $1.8bn33 holders, $14.1bn
Q4 202014 holders, $1.9bn29 holders, $17.3bn
Q1 202110 holders, $3.0bn24 holders, $23.0bn
Q2 20218 holders, $3.7bn24 holders, $27.8bn
Q3 20217 holders, $2.6bn31 holders, $29.9bn
Q4 20217 holders, $2.9bn31 holders, $34.7bn
Q1 20225 holders, $849m24 holders, $35.3bn
Q2 20225 holders, $642m33 holders, $42.7bn
Q3 20225 holders, $425m31 holders, $43.4bn
Q4 20226 holders, $546m31 holders, $46.6bn
Q1 202310 holders, $995m33 holders, $44.3bn
Q2 202311 holders, $1.4bn37 holders, $59.6bn
Q3 202312 holders, $1.3bn44 holders, $67.6bn
Q4 20239 holders, $1.7bn45 holders, $73.6bn
Q1 202410 holders, $1.2bn41 holders, $95.3bn
Q2 20246 holders, $289m43 holders, $110bn
Q3 20247 holders, $337m45 holders, $107bn
Q4 20246 holders, $247m46 holders, $93.9bn
Q1 20257 holders, $165m42 holders, $98.4bn
Q2 20258 holders, $231m43 holders, $93.2bn
Q3 20256 holders, $187m39 holders, $86.7bn
Q4 20255 holders, $272m41 holders, $123bn
Q1 20262 holders, $259m39 holders, $106bn
Q2 20265 holders, $1.2bn44 holders, $132bn
TXG

10X Genomics Inc

Holders
5
Reported value
$1.2bn
Buyers
15
Sellers
16

Breadth -1 among 91 comparable managers.

Medical devices and instrumentsHealthcare: biopharma and medtech · L3VLUP
LLY

Eli Lilly & Co

Holders
44
Reported value
$132bn
Buyers
24
Sellers
24

Breadth 0 among 91 comparable managers.

Pharmaceuticals and biotechnologyHealthcare: biopharma and medtech · L3VLUPPharmaceutical preparations

Who holds both, Q2 2026

Among the 45 tracked managers listing any of them. "Only" is about listed positions: a manager may hold the other below its listed range.

Only TXG (1)

Point72 Asset Management LP

Only LLY (40)

Acadian Asset Management LLC, AllianceBernstein LP, AQR Capital Management LLC, Arrowstreet Capital LP, Artisan Partners LP, Balyasny Asset Management LLC, Brevan Howard Capital Management LP, Bridgewater Associates LP, Capital Research Global Investors, Citadel Advisors LLC, D. E. Shaw & Co., Discovery Capital Management LLC, Dodge & Cox, ExodusPoint Capital Management LP, Freestone Grove Partners LP, GAMCO Investors Inc, Glenview Capital Management LLC, Harris Associates LP, Holocene Advisors LP, Hudson Bay Capital Management LP, Invesco Ltd, Jane Street Group LLC, Janus Henderson Group Ltd, Man Group PLC, Marshall Wace LLP, and 15 more

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.

Back to the 13F Explorer →